REG-BARCLAYS PLC Form 8.3 - WILLIS TOWERS WATSON PLC - Amendment
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20201221:nBw8bzPXra&default-theme=true
Form 8.3 - WILLIS TOWERS WATSON PLC - Amendment
Ap19
FORM 8.3 Amendment to Purchase and Sales
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 16 December 2020
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
3,064,072 2.38% 689,587 0.53%
(2) Derivatives (other than options):
365,705 0.28% 739,005 0.57%
(3) Options and agreements to
purchase/sell: 0 0.00% 0 0.00%
TOTAL:
3,429,777 2.66% 1,428,592 1.11%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
Ap20
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 1 211.9300 USD
Purchase 1 212.0300 USD
Purchase 3 211.3566 USD
Purchase 7 212.7828 USD
Purchase 8 212.3462 USD
Purchase 9 212.6044 USD
Purchase 26 212.4417 USD
Purchase 34 212.3200 USD
Purchase 34 212.2900 USD
Purchase 38 212.4944 USD
Purchase 39 212.5900 USD
Purchase 40 212.4050 USD
Purchase 41 212.5563 USD
Purchase 42 212.6440 USD
Purchase 42 212.5192 USD
Purchase 45 212.4715 USD
Purchase 46 212.4126 USD
Purchase 48 212.5612 USD
Purchase 54 212.6124 USD
Purchase 100 211.7600 USD
Purchase 171 210.0100 USD
Purchase 175 211.6335 USD
Purchase 255 212.1229 USD
Purchase 340 212.1760 USD
Purchase 406 211.9913 USD
Purchase 420 212.2917 USD
Purchase 539 212.0371 USD
Purchase 660 212.2931 USD
Purchase 754 212.1561 USD
Purchase 817 212.4306 USD
Purchase 825 212.0832 USD
Purchase 994 212.0950 USD
Purchase 1,202 212.0013 USD
Purchase 3,640 211.9613 USD
Purchase 3,941 212.3610 USD
Purchase 4,186 212.2792 USD
Purchase 8,310 211.9679 USD
Purchase 11,648 212.1026 USD
Purchase 13,166 211.9800 USD
Purchase 14,452 212.3990 USD
Sale 1 211.0000 USD
Sale 2 210.4500 USD
Sale 2 211.5350 USD
Sale 9 212.6044 USD
Sale 34 212.2900 USD
Sale 100 212.3800 USD
Sale 100 212.3500 USD
Sale 102 212.0350 USD
Sale 143 212.7184 USD
Sale 171 210.0100 USD
Sale 744 212.3117 USD
Sale 1,051 212.5628 USD
Sale 1,632 212.1365 USD
Sale 1,818 212.2410 USD
Sale 2,898 212.2877 USD
Sale 3,640 211.9613 USD
Sale 5,471 212.0146 USD
Sale 6,486 212.1599 USD
Sale 9,908 212.1562 USD
Sale 13,506 212.4046 USD
Sale 20,966 211.9800 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)
e.g. call option
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note
4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
None
Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 21 Dec 2020
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection
View source version on businesswire.com:
https://www.businesswire.com/news/home/20201220005038/en/
(https://www.businesswire.com/news/home/20201220005038/en/)
BARCLAYS PLC
Copyright Business Wire 2020Recent news on Barclays
See all newsREG - Barclays PLC Just Group plc - Form 8.3 JUST GROUP PLC
AnnouncementREG - Barclays PLC NCC Group PLC - Form 8.3 NCC GROUP PLC
AnnouncementREG - Barclays PLC Spire Healthcare Grp - Form 8.3 SPIRE HEALTHCARE GROUP PLC
AnnouncementREG - Barclays PLC Life Science REIT - Form 8.3 LIFE SCIENCE REIT PLC
AnnouncementREG - Barclays PLC British Land Co PLC - Form 8.3 BRITISH LAND COMPANY PLC, THE
Announcement